BioFactors · 2017 · 19 citations · 19 references
Life SciencesImmunologyPharmacologyAllergyInflammationInnate ImmunityAllergic RhinitisAllergic Rhinitis PharmacotherapyAnti-inflammatory PharmacologyCytokine BiologyInnate Immune ModulationRespiratory AllergyAirway Inflammation ModulationAllergic Airway InflammationAnti-inflammatory ActivityAnti-inflammatory Drug MechanismsAnti-inflammatory MechanismsAnti-inflammatory ResponseNasal InflammationPro-inflammatory Cytokine Expression
in allergen-challenged patients. However, the mechanism of action and anti-inflammatory potential in virally induced exacerbation of the upper airways is unknown. This study investigates the anti-inflammatory mechanisms of Ze339 on primary human nasal epithelial cells (HNECs) upon viral, bacterial and pro-inflammatory triggers. To investigate the influence of viral and bacterial infections on the airways, HNECs were stimulated with viral mimics, bacterial toll-like-receptor (TLR)-ligands or cytokines, in presence or absence of Ze339. The study uncovers Ze339 modulated changes in pro-inflammatory mediators and decreased neutrophil chemotaxis as well as a reduction of the nuclear translocation and phosphorylation of STAT molecules. Taken together, this study suggests that phyto drug Ze339 specifically targets STAT-signalling pathways in HNECs and has high potential as a broad anti-inflammatory drug that exceeds current indication. © 2016 BioFactors, 43(3):388-399, 2017.
19
John F. DiPersio, P Billing, Rhonda Williams et al. · The Journal of Immunology · 1988 · 187 citations · Full text
Christoph A. Reichel, Markus Rehberg, Max Lerchenberger et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 151 citations · Full text